Cutting edge discussions on protein & antibody engineering and development strategies, advancing bispecifics to the clinic & therapeutic use, bioanalysis and vaccine development
The Proteins & Antibodies Congress includes...
Over 300 attendees representing global pharmaceutical organisations, leading biotech and internationally renowned academic institutions.
Over 30 case studies, presentations, panel debates & roundtable discussions focused on the key issues in protein & antibody engineering, characterisation & developability updates and vaccine development.
Supported digitally on our fully featured online event platform, with headline talks live-streaming from the auditorium, selected presentations available to watch on-demand, and extensive networking features.
Last Years Agenda at a Glance
Day One
- Antibody Engineering
- Bioanalysis: Characterization, Developability
Day Two
- Protein Engineering, Design, Selection
- Vaccine Development & Therapeutics
Digital Day
- Presentations & interactive sessions on all above topics